GAFFX
Price
$70.44
Change
+$0.85 (+1.22%)
Updated
Apr 25 closing price
Net Assets
277.5B
IRLNX
Price
$74.51
Change
+$1.16 (+1.58%)
Updated
Apr 25 closing price
Net Assets
1.39B
Ad is loading...

GAFFX vs IRLNX

Header iconGAFFX vs IRLNX Comparison
Open Charts GAFFX vs IRLNXBanner chart's image
American Funds Growth Fund of Amer F3
Price$70.44
Change+$0.85 (+1.22%)
VolumeN/A
Net Assets277.5B
Voya Russell Large Cap Growth Idx Port I
Price$74.51
Change+$1.16 (+1.58%)
VolumeN/A
Net Assets1.39B
GAFFX vs IRLNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. IRLNX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and IRLNX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 277B vs. IRLNX (1.39B). GAFFX pays higher dividends than IRLNX: GAFFX (0.72) vs IRLNX (0.39). GAFFX was incepted earlier than IRLNX: GAFFX (8 years) vs IRLNX (16 years). IRLNX (0.55) is less costly to investors than GAFFX (0.30). IRLNX is a more actively managed with annual turnover of: 36.00 vs. GAFFX (25.00). IRLNX has a lower initial minimum investment than GAFFX: IRLNX (0) vs GAFFX (1000000). IRLNX annual gain was more profitable for investors over the last year : 10.25 vs. GAFFX (3.80). IRLNX return over 5 years is better than : 82.76 vs. GAFFX (47.95).
GAFFXIRLNXGAFFX / IRLNX
Total Expense Ratio0.300.4370%
Annual Report Gross Expense Ratio0.300.5555%
Fund Existence8 years16 years-
Gain YTD-5.412-9.25658%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets277B1.39B20,000%
Annual Yield % from dividends0.720.39183%
Returns for 1 year3.8010.2537%
Returns for 3 years21.5628.3376%
Returns for 5 years47.9582.7658%
Returns for 10 yearsN/A213.69-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBR29.830.27
+0.91%
Nabors Industries Ltd
NERV1.760.01
+0.57%
Minerva Neurosciences
AKRO41.000.01
+0.02%
Akero Therapeutics
LH228.31-0.27
-0.12%
Laboratory Corp
YMAB4.10-0.03
-0.73%
Y-mAbs Therapeutics